Quantinno Capital Management LP lessened its holdings in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 63.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 226,690 shares of the company's stock after selling 391,358 shares during the quarter. Quantinno Capital Management LP owned approximately 0.49% of Azenta worth $4,790,000 at the end of the most recent quarter.
Several other institutional investors have also recently added to or reduced their stakes in AZTA. Caitong International Asset Management Co. Ltd lifted its position in shares of Azenta by 2,067.6% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 802 shares of the company's stock worth $27,000 after buying an additional 765 shares during the last quarter. Assetmark Inc. grew its position in shares of Azenta by 54.1% during the 4th quarter. Assetmark Inc. now owns 832 shares of the company's stock valued at $28,000 after buying an additional 292 shares during the last quarter. State of Wyoming acquired a new stake in Azenta during the first quarter worth about $38,000. Osaic Holdings Inc. lifted its holdings in Azenta by 44.9% in the second quarter. Osaic Holdings Inc. now owns 1,242 shares of the company's stock worth $39,000 after acquiring an additional 385 shares during the last quarter. Finally, Rockefeller Capital Management L.P. lifted its holdings in Azenta by 98.0% in the fourth quarter. Rockefeller Capital Management L.P. now owns 1,392 shares of the company's stock worth $46,000 after acquiring an additional 689 shares during the last quarter. Institutional investors own 99.08% of the company's stock.
Analysts Set New Price Targets
Several equities analysts have recently commented on AZTA shares. Weiss Ratings raised Azenta from a "sell (e+)" rating to a "sell (d-)" rating in a report on Wednesday, July 15th. Needham & Company LLC boosted their price objective on Azenta from $33.00 to $37.00 and gave the company a "buy" rating in a research report on Wednesday. Four equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, Azenta has an average rating of "Hold" and a consensus target price of $41.20.
Check Out Our Latest Analysis on Azenta
Azenta Trading Down 3.4%
Azenta stock opened at $30.74 on Friday. The company's 50-day moving average price is $25.44 and its two-hundred day moving average price is $25.48. The stock has a market cap of $1.42 billion, a price-to-earnings ratio of -11.14 and a beta of 1.37. Azenta, Inc. has a 52 week low of $15.93 and a 52 week high of $41.73.
Azenta (NASDAQ:AZTA - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.05. Azenta had a negative net margin of 20.63% and a positive return on equity of 1.18%. The business had revenue of $161.18 million during the quarter, compared to analysts' expectations of $149.31 million.
Azenta Profile
(
Free Report)
Azenta, Inc NASDAQ: AZTA is a life sciences technology company specializing in sample management, cryogenic storage and genomic services for research and clinical applications. Formerly the Life Sciences division of Brooks Automation, Azenta provides integrated solutions that enable customers to store, track and analyze biological samples with high levels of automation, data integrity and efficiency. Its offerings span automated storage systems, biorepository management software and end‐to‐end sample tracking workflows.
In addition to hardware and informatics platforms for sample storage, Azenta's Genomics business delivers next‐generation sequencing (NGS), DNA synthesis, and molecular biology services.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
